Also the point of the quarterly is to highlight the key outcomes for the quarter. And that was the launch of ptx-100 phase 1b. I really don’t think there’s anything to worry about in relation to ptx-200 - there was just nothing to really report for the quarter.
don’t forget also the breast cancer trial finished recruiting in July
Ann: September 2019 Appendix 4C - Quarterly, page-26
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $34.62M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.5¢ | 4.3¢ | $17.99K | 416.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 152502 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 502504 | 5 |
View Market Depth
| Last trade - 15.59pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.3¢ |
Change
-0.001 ( 4.44 %) |
||||
| Open | High | Low | Volume | ||
| 4.3¢ | 4.5¢ | 4.3¢ | 123400 | ||
| Last updated 15.57pm 17/05/2024 ? | |||||
| PTX (ASX) Chart |